Legalize Psychedelic Medicine

Donate to MAPS' Phase 3 Studies of MDMA-Assisted Psychotherapy for PTSD in Europe

We have nearly completed funding our Phase 3 trials for FDA approval in the U.S. of MDMA-assisted psychotherapy for the treatment of PTSD. However, MAPS still needs approximately $5 million to conduct Phase 3 studies in Europe and seek regulatory approval from the European Medicines Agency (EMA). We aim to make MDMA-assisted psychotheray a legal treatment by 2021 in both the U.S. and Europe.


If you have a MAPS account, please log in HERE and your contact information will be filled in automatically.

Your Information


Create Account

If you would like to make a MAPS account, which will enable you to update your address and payment information, view your donation history, and more, please create a login name and password:

Neon CRM by Neon One